Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

People undergoing chemotherapy need better support and information to cope with hair loss.

Juniperus plants contain compounds with potential for developing various medical treatments.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Early-stage skin cells help regenerate hair follicles, with proteins SDF1, MMP3, biglycan, and LTBP1 playing key roles.

Proper education can prevent traction alopecia in women of color.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Follicular Unit Transplantation is an effective and safe treatment for hair loss due to scarring.

The study introduced a new imaging technology to track skin healing and bone marrow cell activity over time.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Hair follicle regeneration may slow tumor growth.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The HOXC13 gene affects different hair proteins in cashmere goats in varied ways and is controlled by a feedback loop and other factors.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

FDG PET/CT scans can change cancer treatment plans for dogs.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The rapid corticotropin test is a quick and simple way to diagnose adrenal insufficiency.

3D cell-derived matrices improve tissue regeneration and disease modeling.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Hair gets thinner and grayer with age, and density decreases more in men on top and in women on top and back.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Women with greater androgen sensitivity respond better to finasteride for hair loss.